| |
|
|
|
Xtalks, online
2023 -6-27
This webinar will focus on non-invasive approaches to NAFLD/NASH drug development. During the webinar, speakers will provide updates on current and emerging NASH biomarkers, which are also anticipated to be important tools in clinical practice. The audience will learn how data generated from these biomarker tests can inform clinicians, identify treatment efficacy and lead to identification of new biomarker targets.
Join this informative webinar on non-invasive strategies for NAFLD/NASH drug development. Gain valuable knowledge about the latest NASH biomarkers and their practical applications in clinical settings.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Margery A. Connelly, PhD, MBA, FAHA, Strategic Director, Diagnostics R&D, Labcorp Katherine T. Landschulz, PhD, Senior Director and Therapeutic Area Lead, Cardiovascular/Metabolic/Renal Disease, NAFLD/NASH, Neurodegenerative Diseases, Biomarker Solution Center, Labcorp Dr. Mohammad Shadab Siddiqui, MD, Associate Professor, Gastroenterology and Hepatology, Virginia Commonwealth University
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -6-27
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|